- Home
- GBR vs INBS Comparison
GBR vs INBS Comparison
Compare GBR & INBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GBR
- INBS
- Stock Information
- Founded
- GBR 1978
- INBS 2016
- Country
- GBR United States
- INBS United States
- Employees
- GBR N/A
- INBS N/A
- Industry
- GBR Oil & Gas Production
- INBS Medical Specialities
- Sector
- GBR Energy
- INBS Health Care
- Exchange
- GBR Nasdaq
- INBS Nasdaq
- Market Cap
- GBR 6.0M
- INBS 6.3M
- IPO Year
- GBR N/A
- INBS N/A
- Fundamental
- Price
- GBR $1.18
- INBS $1.48
- Analyst Decision
- GBR
- INBS
- Analyst Count
- GBR 0
- INBS 0
- Target Price
- GBR N/A
- INBS N/A
- AVG Volume (30 Days)
- GBR 15.7K
- INBS 132.9K
- Earning Date
- GBR 11-13-2024
- INBS 11-07-2024
- Dividend Yield
- GBR N/A
- INBS N/A
- EPS Growth
- GBR N/A
- INBS N/A
- EPS
- GBR N/A
- INBS N/A
- Revenue
- GBR $147,000.00
- INBS $3,187,974.00
- Revenue This Year
- GBR N/A
- INBS $280.88
- Revenue Next Year
- GBR N/A
- INBS $126.26
- P/E Ratio
- GBR N/A
- INBS N/A
- Revenue Growth
- GBR N/A
- INBS 55.29
- 52 Week Low
- GBR $0.95
- INBS $1.00
- 52 Week High
- GBR $1.82
- INBS $11.70
- Technical
- Relative Strength Index (RSI)
- GBR 46.70
- INBS 45.87
- Support Level
- GBR $1.13
- INBS $1.36
- Resistance Level
- GBR $1.25
- INBS $1.99
- Average True Range (ATR)
- GBR 0.06
- INBS 0.18
- MACD
- GBR 0.00
- INBS 0.01
- Stochastic Oscillator
- GBR 37.50
- INBS 19.17
About GBR New Concept Energy Inc
New Concept Energy Inc is a United States-based company engaged in Real Estate Operations. It intends to continue to operate and or sell its West Virginia property. It provides advisory and management services for an independent West Virginia oil and gas company. The Company seeks to establish or acquire new business operations. It operates in one segment, which is real estate rental.
About INBS Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company business through two operating segments include Commercially available Intelligent Fingerprinting Products (IFPG or IFPG segment) and, Development Stage Biosensor Platform Technology (BPT segment).